Comparative Study
7
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
ENDOMETRIOSIS - MRI
Comparative Evaluation of smART+ REE Module to an FDA-cleared Device, for REE Calculation in ICU Patients
Parental Perceptions and Acceptance of Silver Diamine Fluoride in Spain and Italy
Soft Tissue Graft Versus Acellular Dermal Matrix in Preservation of Buccal Plate of Bone
Effect of Unani Medicine for the Management of Anomalies Associated With Polycystic Ovarian Syndrome
Preoperative Treatment of Malleolar Fractures
An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens